Literature DB >> 15785892

Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.

Wilbur B Bowne1, Byrne Lee, W Douglas Wong, Leah Ben-Porat, Jinru Shia, Alfred M Cohen, Warren E Enker, Jose G Guillem, Philip B Paty, Martin R Weiser.   

Abstract

PURPOSE: Locoregional recurrence after resection of colon carcinoma is an uncommon and difficult clinical problem. Outcome data to guide surgical management are limited. This investigation was undertaken to review our experience with surgical resection for patients with locoregional recurrence colon cancer, determine predictors of respectability, and define prognostic factors associated with survival. PATIENTS AND METHODS: A prospective database was queried for patients who had recurrent colon cancer between January 1991 and October 2002. Patients were selected for analysis if they had either isolated resectable locoregional recurrence or concomitant resectable distant disease. Disease-specific survival analysis was performed with the Kaplan-Meier actuarial method, and factors associated with outcome were determined by the log-rank test and Cox regression.
RESULTS: During this period of time, 744 patients with recurrent colon cancer were identified and 100 (13.4 percent) underwent exploration with curative intent for potentially resectable locoregional recurrence: 75 with isolated locoregional recurrence, and 25 with locoregional recurrence and resectable distant disease. The median follow-up for survivors was 27 months. Locoregional recurrence was classified into four categories: anastomotic; mesenteric/nodal; retroperitoneal; and peritoneal. Median survival for all patients was 30 months. Fifty-six patients had an R0 resection (including distant sites). Factors associated with prolonged disease-specific survival included R0 resection (P < 0.001); age <60 years (P < 0.01); early stage of primary disease (P = 0.05); and no associated distant disease (P = 0.03). Poor prognostic factors included more than one site of recurrence (P = 0.05) and involvement of the mesentery/nodal basin (P = 0.03). The ability to obtain an R0 resection was the strongest predictor of outcome, and these patients had a median survival of 66 months.
CONCLUSION: Salvage surgery for locoregional recurrence colon cancer is appropriate for select patients. Complete resection is critical to long-term survival and is associated with a single site of recurrence, perianastomotic disease, low presalvage carcinembryonic antigen level, and absence of distant disease.

Entities:  

Mesh:

Year:  2005        PMID: 15785892     DOI: 10.1007/s10350-004-0881-8

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  33 in total

1.  Laparoscopic salvage surgery for recurrent and metachronous colorectal cancer: 15 years' experience in a single center.

Authors:  Soo Yeun Park; Gyu-Seog Choi; Soo Han Jun; Jun-Seok Park; Hye Jin Kim
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

2.  Therapeutic management and outcome of locoregional recurrence after curative colorectal cancer therapy-a single-center analysis.

Authors:  Pamela Kogler; Reinhold Kafka-Ritsch; Michael Sieb; Arpad Sztankay; Johann Pratschke; Matthias Zitt
Journal:  J Gastrointest Surg       Date:  2014-08-27       Impact factor: 3.452

Review 3.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

Review 4.  Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives.

Authors:  Markus Rentsch; Tobias Schiergens; Andrej Khandoga; Jens Werner
Journal:  Visc Med       Date:  2016-06-13

5.  Loss of APAF-1 expression is associated with early recurrence in stage I, II, and III colorectal cancer.

Authors:  Byung Kyu Ahn; Sung Hoo Kim; Seung Sam Paik; Kang Hong Lee
Journal:  Langenbecks Arch Surg       Date:  2016-08-02       Impact factor: 3.445

6.  Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection.

Authors:  Agostino Chiaravalloti; Alessandro Fiorentini; Erika Palombo; Davide Rinino; Annamaria Lacanfora; Roberta Danieli; Carmen Di Russo; Daniele Di Biagio; Ettore Squillaci; Orazio Schillaci
Journal:  Oncol Lett       Date:  2016-09-15       Impact factor: 2.967

7.  Surgical management of locally advanced and locally recurrent colon cancer.

Authors:  Ron G Landmann; Martin R Weiser
Journal:  Clin Colon Rectal Surg       Date:  2005-08

8.  Reoperation for recurrent colorectal cancer.

Authors:  Michael D Hellinger; Cesar A Santiago
Journal:  Clin Colon Rectal Surg       Date:  2006-11

9.  Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.

Authors:  J H Lee; Chang Min Park; I Joo; Y J Suh; E J Hwang; H Kim; J M Goo
Journal:  Eur Radiol       Date:  2018-10-22       Impact factor: 5.315

10.  The Impact of a Multivisceral Resection and Adjuvant Therapy in Locally Advanced Colon Cancer.

Authors:  Lieve G J Leijssen; Anne M Dinaux; R Amri; Hiroko Kunitake; Liliana G Bordeianou; David L Berger
Journal:  J Gastrointest Surg       Date:  2018-10-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.